Novel Mechanisms Underlying Immune-Checkpoint Inhibitors-Related Diabetes and Resistance in Cancer Treatment

London South Bank University is offering a PhD position in Human Sciences within the Cancer, Infection, and Therapeutics research group led by Professor Eiman Aleem. The research will focus on novel mechanisms underlying immune-checkpoint inhibitors-related diabetes and resistance in cancer treatment. The opportunity is supported by a Chancellor's Scholarship, which includes a tuition waiver. Applicants should have a background in biomedical sciences, biology, medical science, or related fields, and an interest in cancer research, immunology, or diabetes. The application deadline is September 24, 2025. Interested candidates should send their CV to Professor Aleem for initial screening. For more details, candidates can visit the LSBU Research Scholarships webpage. This position provides a chance to contribute to groundbreaking research in healthcare and join a dynamic research group at a leading UK university.